Clinically, when a patient shows radiological signs of recurrence, it is important to know how often HER2 expression changes to a lower level in the metastatic setting, particularly whether a previously HER2-low/ultra-low tumor has converted to HER2-null or 09. The gene discussed is ERBB2; the disease is neoplasm.